NutriChem's LDN Book Events with Shannon Kenrick-Rochon, NP (Low dose naltrexone) from LDN Research Trust on Vimeo.

Scientists Think They've Figured Out What's Triggering Brain Fog in COVID-19 Patients

MSN News Science Alert
11 February 2021
https://www.msn.com/en-us/news/technology/scientists-think-theyve-figured-out-whats-triggering-brain-fog-in-covid-19-patients/ar-BB1dBTTF?li=BBnbfcL

Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients

Cancer Cell
16 January 2021
https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00051-9

Low-dose naltrexone: tricking the body to heal itself

Exp Biol Med (Maywood)
September 2011
https://www.sciencedaily.com/releases/2011/09/110902133047.htm

Low-Dose Naltrexone for Pruritus in Systemic Sclerosis

Int J Rheumatol
12 September 2011
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171757/

Low Dose Naltrexone Treatment of Established Relapsing-Remitting Experimental Autoimmune Encephalomyelitis

J Multiple Sclerosis
January 2015
https://www.researchgate.net/publication/281496691_Low_Dose_Naltrexone_Treatment_of_Established_Relapsing-Remitting_Experimental_Autoimmune_Encephalomyelitis

Featured Article: Serum [Met 5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone

Exp Biol Med (Maywood)
September 2017
https://pubmed.ncbi.nlm.nih.gov/28766982/

Emerging Unconventional Therapies for Alopecia Areata

J Investig Dermatol Symp Proc
January 2018
https://pubmed.ncbi.nlm.nih.gov/29273103/

Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis

Exp Biol Med (Maywood)
February 2018
https://pubmed.ncbi.nlm.nih.gov/29307283/

The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia

Int J Pharm Compd
June 2018
https://pubmed.ncbi.nlm.nih.gov/29878893/